silybin has been researched along with u 0126 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PN; Chiou, HL; Chu, SC; Hsieh, YS | 1 |
| Choe, JH; Hur, SM; Kim, JH; Kim, JS; Kim, S; Kim, SH; Kim, WW; Lee, JE; Lee, SK; Nam, SJ; Yang, JH | 1 |
| Han, J; Jung, SP; Kim, JH; Kim, JS; Kim, S; Lee, JE; Nam, SJ; Oh, SJ | 1 |
3 other study(ies) available for silybin and u 0126
| Article | Year |
|---|---|
Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways.
Topics: Anticarcinogenic Agents; Butadienes; Cell Line, Tumor; Cell Movement; Chromones; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Lung Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinases; Morpholines; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Plant Extracts; Silybin; Silybum marianum; Silymarin; Urokinase-Type Plasminogen Activator | 2005 |
Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Butadienes; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2; Down-Regulation; Humans; MAP Kinase Kinase Kinases; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Nitriles; Phytotherapy; Protein Kinase Inhibitors; Pyrazoles; Seeds; Silybin; Silybum marianum; Silymarin; Sulfonamides; Tetradecanoylphorbol Acetate | 2009 |
Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.
Topics: Breast Neoplasms; Butadienes; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 9; MCF-7 Cells; Neoplasm Invasiveness; Nitriles; Phosphorylation; Silybin; Silymarin; Tetradecanoylphorbol Acetate; Thyroid Neoplasms | 2013 |